by Alex Kadhim
Researchers found that mitochondrial DNA (mtDNA) variation may improve prediction of graft-versus-host disease (GVHD) risk after allogeneic hematopoietic cell transplantation beyond traditional...
by Alex Kadhim
Researchers identified donor T-cell clones associated with severe graft-versus-host disease (GVHD) before transplantation and tracked their expansion and migration after transplant. The findings...
by Alex Kadhim
Researchers identified a subset of glioblastomas with high levels of tumor-infiltrating lymphocytes (TIL) that contained clonally expanded, exhausted CD8⁺ T cells marked by LAG3, suggesting the...
by Alex Kadhim
Researchers found that malignant pleural effusion (MPE) may serve as a minimally invasive source of tumor-reactive T cells for tumor-infiltrating lymphocyte (TIL) therapy. Compared with surgically...
by ASTCT Staff
In this Q&A, lead author Sairah Ahmed, MD, professor in the division of cancer medicine at The University of Texas MD Anderson Cancer Center, discusses the evidence behind the new guidance,...
by ASTCT Staff
In this Q&A, Sergio A. Giralt, MD, FACP, FASTCT, Melvin Berlin Family Chair in Multiple Myeloma and deputy head of the division of hematologic malignancies at Memorial Sloan Kettering Cancer...